[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Tourmaline Bio, Inc. Common Stock](/topic/$trml)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$trml/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$trml/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% +42%  
**1 Year**: XX% +30%  
**1-Year High**: XXX% on 2024-10-20  
**1-Year Low**: XX% on 2025-05-03  

**Most Supportive Themes**
- **Acquisition by Novartis:** (60%) The acquisition of Tourmaline Bio by Novartis for $XX per share is a major positive catalyst.
- **52-Week Highs and Momentum:** (25%) Posts highlight the stock reaching 52-week highs and strong pre-market momentum.
  
**Most Critical Themes**
- **Downgrades:** (15%)  Some analysts have downgraded the stock, which could temper enthusiasm.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | X        | X% | XXX     | XX% | X        | X% |
|         |          |    |         |     |          |    |
| Total   | X        | X% | XXX     | XX% | X        | X% |